Impact of Smoking on Outcomes of HPV-related Oropharyngeal Cancer Treated with Primary Radiation or Surgery

International Journal of Radiation Oncology Biology Physics

Volumn 103, Issue 5, 2019, Pages 1125-1131

  Vawda, Nafeesa ^a   Banerjee, Robyn N ^b   Debenham, Brock J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIORAL RESEARCH; DISEASES; SURGERY; TUMORS; VIRUSES;

BIOLOGICAL BEHAVIOR; CHEMORADIATION THERAPIES; HUMAN PAPILLOMA VIRUS; KAPLAN-MEIER METHOD; METHODS AND MATERIALS; OROPHARYNGEAL CANCER; OROPHARYNGEAL CARCINOMATA; RECURRENCE-FREE SURVIVAL;

SMOKE;

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL OUTCOME; CONTROLLED STUDY; EX-SMOKER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MIDDLE AGED; OROPHARYNX CANCER; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SMOKING; ADVERSE EVENT; AGED; COMPLICATION; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; KAPLAN MEIER METHOD; MORTALITY; OROPHARYNX TUMOR; RADIOTHERAPY DOSAGE; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; EX-SMOKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NON-SMOKERS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SMOKERS; SMOKING; TIME FACTORS; TREATMENT OUTCOME;

EID: 85060345972     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2018.11.046     Document Type: Article

References (27)

1. Chaturvedi, A.K., Anderson, W.F., Lortet-Tieulent, J., et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 31 (2013), 4550–4559.
2. Kreimer, A.R., Clifford, G.M., Boyle, P., Franceschi, S., Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev 14 (2005), 467–475.
3. Mehanna, H., Beech, T., Nicholson, T., et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta-analysis of trends by time and region. Head Neck 35 (2013), 747–755.
4. Chaturvedi, A.K., Engels, E.A., Pfeiffer, R.M., et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29 (2011), 4294–4301.
5. Dayyani, F., Etzel, C.J., Liu, M., et al. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol, 2, 2010, 15.
6. Fakhry, C., Westra, W.H., Li, S., et al. Improved survival of patients with human papillomavirus–positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100 (2008), 261–269.
7. Ang, K.K., Harris, J., Wheeler, R., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363 (2010), 24–35.
8. Ragin, C.C., Taioli, E., Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis. Int J Cancer 121 (2007), 1813–1820.
9. Hafkamp, H.C., Manni, J.J., Haesevoets, A., et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 122 (2008), 2656–2664.
10. Gillison, M.L., Zhang, Q., Jordan, R., et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 30 (2012), 2102–2111.
11. Peppone, L.J., Mustian, K.M., Morrow, G.R., et al. The effect of cigarette smoking on cancer treatment related side effects. Oncologist 16 (2011), 1784–1792.
12. Browman, G.P., Wong, G., Hodson, I., et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328 (1993), 159–163.
13. NCCN practice guidelines for head and neck version 2, 2017 Available at: https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf Accessed March 8, 2018.
14. Masterson, L., Moualed, D., Liu, Z.W., et al. De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis of current clinical trials. Eur J Cancer 50 (2014), 2636–2648.
15. Hong, A.M., Martin, A., Chatfield, M., et al. Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma. Int J Cancer 132 (2013), 2748–2754.
16. Laco, J., Nekvindova, J., Novakova, V., et al. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status. Neoplasma 59 (2012), 398–408.
17. Maxwell, J.H., Ferris, R.L., Gooding, W., et al. Extracapsular spread in head and neck carcinoma: Impact of site and human papillomavirus status. Cancer 119 (2013), 3302–3308.
18. Maxwell, J.H., Kumar, B., Feng, F.Y., et al. Tobacco use in HPV-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res 16 (2010), 1226–1235.
19. Hong, A.M., Dobbins, T.A., Lee, C.S., et al. Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer 103 (2010), 1510–1517.
20. Park, G., Lee, S.W., Kim, S.Y., et al. Can concurrent chemoradiotherapy replace surgery and postoperative radiation for locally advanced stage III/IV tonsillar squamous cell carcinoma?. Anticancer Res 33 (2013), 1237–1243.
21. Boscolo-Rizzo, P., Gava, A., Baggio, V., et al. Matched survival analysis in patients with locoregionally advanced resectable oropharyngeal carcinoma: Platinum-based induction and concurrent chemoradiotherapy versus primary surgical resection. Int J Radiat Oncol Biol Phys 80 (2011), 154–160.
22. Kano, S., Homma, A., Hayashi, R., et al. Matched-pair analysis in patients with advanced oropharyngeal cancer: Surgery versus concurrent chemoradiotherapy. Oncology 84 (2013), 290–298.
23. Chen, A.Y., Zhu, J., Fedewa, S., Temporal trends in oropharyngeal cancer treatment and survival: 1998-2009. Laryngoscope 124 (2014), 131–138.
24. Lohavanichbutr, P., Houck, J., Fan, W., et al. Genomewide gene expression profiles of hpv-positive and hpv-negative oropharyngeal cancer: Potential implications for treatment choices. Arch Otolaryngol Head Neck Surg 135 (2009), 180–188.
25. Hayes, D.N., Van Waes, C., Seiwert, T.Y., Genetic landscape of human papillomavirus–associated head and neck cancer and comparison to tobacco-related tumors. J Clin Oncol 33 (2015), 3227–3234.
26. Kumar, B., Cordell, K.G., Lee, J.S., et al. EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 26 (2008), 3128–3137.
27. Zevallos, J.P., Yim, E., Brennan, P., et al. Molecular profile of human papillomavirus–positive oropharyngeal squamous cell carcinoma stratified by smoking status. Int J Radiat Oncol Biol Phys, 94, 2016, 864.